
-
Solid Biosciences NASDAQ:SLDB
Location: | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
269.7M
Cash
148.9M
Avg Qtr Burn
-25.0M
Short % of Float
18.64%
Insider Ownership
0.45%
Institutional Own.
62.23%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SGT-003 Details Genetic disorder, Duchenne muscular dystrophy | Phase 1/2 Update | |
SGT-212 (dual route) Details Friedreich’s Ataxia | Phase 1b Initiation | |
SGT-501 (Cardiac Gene Therapy) Details Catecholaminergic Polymorphic Ventricular Tachycardia, Heart disease, Gene & Cell therapies | IND Submission | |
SGT-001 (Microdystrophin Gene Transfer) Details Genetic disorder, Muscle weakness, Muscle degeneration | Failed Discontinued |